Gene Therapy for X-CGD

NCT01906541 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

5

Enrollment

OTHER

Sponsor class

Conditions

X-linked Chronic Granulomatous Disease

Interventions

GENETIC: ex-vivo gene-therapy

Sponsor

Hubert Serve, Prof., MD